Physician profile
Prateek Mathur
NPI 1538510201
$915.86
in general payments reported to CMS, 2019-2025
9 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.27 · 2020: $21.17 · 2023: $244 · 2024: $446 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enterra Medical, INC. | $431.84 | 2024-2025 | |
| Medtronic, INC. | $251.57 | 2023-2025 | Gi Genius, Nexpowder, Pillcam |
| Abbvie INC. | $54.33 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.50 | 2019-2023 | Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.43 | 2023 | Xifaxan |
| Pfizer INC. | $25.62 | 2019 | |
| Gilead Sciences, INC. | $25.19 | 2024 | |
| Melinta Therapeutics, LLC | $21.17 | 2020 | |
| Boston Scientific Corporation | $14.21 | 2023 | Wallflex Duodenal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prateek Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.